Search
-
Ipsos Update - June 2020
Welcome to June’s edition of Ipsos Update – our round-up of the latest research and thinking from Ipsos teams around the world. It includes features on future scenario planning, customer experience, the emerging health and safety agenda, attitudes to work, and public opinion from New Zealand and Australia.
-
AAPOR Virtual Meeting
Ipsos is delighted to be sponsoring this year’s annual AAPOR Conference. In addition, we are proud to have a number of seasoned experts join the speaker list including Clifford Young, President of Ipsos Public Affairs U.S. who will be moderating a panel discussion around Innovations in Online Probability-Based Panels - A Look at the Last 20 Years and Beyond.
-
Preparing for the future of the operating room: Robotics
Imagine a future where surgical robots have become standard even in non-specialized hospitals and outpatient clinics outside of a major metropolis.
-
Maria Perez will lead Fast-Response DIY Platform Ipsos.Digital in North America
Late last year, Ipsos launched its innovative market research tool, Ipsos.Digital– a fully automated self-service research platform, which functions as a Do-it-yourself (DIY) or Do-it-together tool for clients
-
How brands can help consumers navigate the path to restoration
Read more about the coronavirus continuum, and what the path back to normal might look like.
-
Social Data Summit
Please join Ipsos’ Steve Reeves to hear more about Eating for Health: Mapping Trends Through a Consumer-Driven Lens.
-
Equality Lounge Virtual Briefing: Positivity & Proactivity
Join Ipsos’ Lauren Demar for a panel discussion about Creating the New Normal.
-
Managing Brand Saliency and Perceived Value Amidst Covid-19
We offer 3 reasons why brand managers must adapt their strategy to align with the new drivers of perceived value and fence off competition from private labels.
-
Redefining risk in medical device markets in the time of Covid-19
Read our white paper to review key considerations for medical device companies to redefine risk, identify opportunities and adapt during Covid-19
-
Evaluating and adapting your soon-to-launch pharma strategy
Covid-19 has greatly disrupted the channels of communication between healthcare professionals and pharma manufacturers, especially those preparing for a product launch.